ASTRO 2025: Daily Online Adaptive Recontouring for Prostate Cancer Using 1.5 Tesla Magnetic Resonance Image Guidance (MRgRT) Improves Patient Reported Urinary Symptoms, A Prospective, International, Observational Cohort Study (NCT04075305) – UroToday

  1. ASTRO 2025: Daily Online Adaptive Recontouring for Prostate Cancer Using 1.5 Tesla Magnetic Resonance Image Guidance (MRgRT) Improves Patient Reported Urinary Symptoms, A Prospective, International, Observational Cohort Study (NCT04075305)  UroToday
  2. Elekta : Study shows MRI-guided adaptive radiotherapy with Elekta Unity improves patient-reported urinary symptoms in men with prostate cancer  MarketScreener
  3. Elekta Unity Enhances Prostate Cancer Treatment Outcomes  TipRanks

Continue Reading